ADC Therapeutics SA (ADCT) Free cash flow 2022–2025
ADC Therapeutics SA (ADCT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$141.4MFY2025 · since FY2022: -$139.0M → -$141.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$141.4M | -13.4% |
| FY2024 | -$124.7M | -2.3% |
| FY2023 | -$121.9M | +12.3% |
| FY2022 | -$139.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice